Average Co-Inventor Count = 1.94
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Supernus Pharmaceuticals, Inc. (10 from 78 patents)
2. Otsuka Pharmaceutical Company, Limited (5 from 846 patents)
3. Supermus Pharmaceuticals, Inc. (1 from 1 patent)
4. Tcd Royalty Sub, LLC (0 patent)
16 patents:
1. 11400087 - Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
2. 11344547 - Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
3. 11154553 - Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
4. 10980803 - Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
5. 10525057 - Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
6. 8709478 - Once daily formulations of tetracyclines
7. 8470364 - Once daily formulations of tetracyclines
8. 8394405 - Once daily formulations of tetracyclines
9. 8394406 - Once daily formulations of tetracyclines
10. 8206740 - Once daily formulations of tetracyclines
11. 7781448 - Once daily dosage forms of trospium
12. 7781449 - Trospium chloride treatment method
13. 7763635 - Once daily dosage forms of trospium
14. 7759359 - Method of treating bladder dysfunction with once-a-day trospium salt formulation
15. 7749532 - Once daily formulations of tetracyclines